Brooks O'Neil
Stock Analyst at Lake Street
(0.94)
# 3,879
Out of 5,056 analysts
36
Total ratings
29.41%
Success rate
-13.57%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $18.06 | -33.55% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $3.78 | +111.64% | 7 | Aug 11, 2025 | |
| LFMD LifeMD | Maintains: Buy | $18 → $14 | $5.07 | +176.13% | 3 | Aug 6, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $7.62 | +162.47% | 2 | Apr 21, 2025 | |
| SRDX Surmodics | Upgrades: Buy | $43 | $41.35 | +3.99% | 4 | Mar 7, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $89.97 | +22.26% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $28.16 | +6.53% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $25.73 | +175.94% | 1 | Jan 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $6.64 | +291.57% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $38.44 | +43.08% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $20.75 | -13.25% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $6.48 | -22.84% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $7.48 | +60.43% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $25.38 | +2.44% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.48 | +2,177.43% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $33.35 | +282.31% | 1 | Sep 15, 2020 |
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $18.06
Upside: -33.55%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.78
Upside: +111.64%
LifeMD
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $14
Current: $5.07
Upside: +176.13%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $7.62
Upside: +162.47%
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $41.35
Upside: +3.99%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $89.97
Upside: +22.26%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $28.16
Upside: +6.53%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $25.73
Upside: +175.94%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $6.64
Upside: +291.57%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $38.44
Upside: +43.08%
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $20.75
Upside: -13.25%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $6.48
Upside: -22.84%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $7.48
Upside: +60.43%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $25.38
Upside: +2.44%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.48
Upside: +2,177.43%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $33.35
Upside: +282.31%